StockNews.com Begins Coverage on Aethlon Medical (NASDAQ:AEMD)

Stock analysts at StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a note issued to investors on Monday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of AEMD stock opened at $0.62 on Monday. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $1.88. The firm has a market capitalization of $8.70 million, a P/E ratio of -0.22 and a beta of 1.61. The stock has a 50 day moving average price of $0.55 and a 200 day moving average price of $0.45.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.